Switch to:
More From Other Websites
Daratumumab Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration in... Jul 25 2016
ETF’s with exposure to Gencor Industries, Inc. : July 18, 2016 Jul 18 2016
GENCOR INDUSTRIES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 11 2016
Gencor Announces 50% Stock Dividend Jul 11 2016
ETF’s with exposure to Gencor Industries, Inc. : July 7, 2016 Jul 07 2016
Genmab Provides Update on Marketing Authorization Application for Arzerra® (ofatumumab) as... Jun 23 2016
Articles of Association for Genmab A/S Jun 14 2016
Grant of Warrants to Genmab Employees Jun 09 2016
Gencor Industries, Inc. :GENC-US: Earnings Analysis: Q2, 2016 By the Numbers : June 8, 2016 Jun 08 2016
Genmab Announces Phase III Studies of Ofatumumab in Relapsing Multiple Sclerosis Jun 02 2016
Genmab's Total Number of Voting Rights and Total Share Capital May 31 2016
Genmab to Present at the Goldman Sachs 37th Annual Global Healthcare Conference May 31 2016
Genmab Achieves USD 30 Million Milestone in DARZALEX® (daratumumab) Collaboration with Janssen May 30 2016
Genmab Announces European Conditional Marketing Authorization for DARZALEX® (daratumumab) for... May 23 2016
First Participants Dosed in Clinical Study with DuoBody® Product May 20 2016
Articles of Association for Genmab A/S May 19 2016
GENCOR INDUSTRIES INC Financials May 19 2016
Daratumumab and Ofatumumab Data to Be Presented at 21st Congress of EHA May 19 2016
Genmab Announces Positive Topline Result in Phase III POLLUX Study of Daratumumab in Relapsed or... May 18 2016
Capital Increase in Genmab as a Result of Employee Warrant Exercise May 18 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)